|
|
|
|
|
Analogs
-
2000919
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 39 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
O77823-1-E |
Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE1A-1-E |
Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
800 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.38 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
40 |
0.52 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3690 |
0.38 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
622 |
0.43 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
Q864F1-1-E |
Phosphodiesterase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
720 |
0.43 |
Binding ≤ 10μM
|
Q8VBU5-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
625 |
0.43 |
Functional ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 1), Other |
Other |
150 |
0.48 |
Binding ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 5), Other |
Other |
7 |
0.57 |
Binding ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z100489-1-O |
Eosinophils (Eosinophils) (cluster #1 Of 1), Other |
Other |
6500 |
0.36 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
340 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
660 |
0.43 |
Functional ≤ 10μM |
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
4 |
0.59 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
40 |
0.52 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
1230 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.67 |
5.43 |
-11.26 |
1 |
4 |
0 |
48 |
275.348 |
4 |
↓
|
|
|
Analogs
-
4982
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 35 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
O77823-1-E |
Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE1A-1-E |
Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
800 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
Q864F1-1-E |
Phosphodiesterase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
720 |
0.43 |
Binding ≤ 10μM
|
Q8VBU5-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
625 |
0.43 |
Functional ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 1), Other |
Other |
150 |
0.48 |
Binding ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 5), Other |
Other |
7 |
0.57 |
Binding ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z100489-1-O |
Eosinophils (Eosinophils) (cluster #1 Of 1), Other |
Other |
6500 |
0.36 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
340 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
660 |
0.43 |
Functional ≤ 10μM |
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
4 |
0.59 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
40 |
0.52 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
1230 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.67 |
5.44 |
-11.23 |
1 |
4 |
0 |
48 |
275.348 |
4 |
↓
|
Ref
Reference (pH 7)
|
2.85 |
2.11 |
-7.58 |
1 |
4 |
0 |
51 |
275.348 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
500 |
0.37 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.42 |
Functional ≤ 10μM
|
Z80055-1-O |
CAKI-1 (Kidney Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.53 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
450 |
0.37 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
82 |
0.41 |
Functional ≤ 10μM
|
Z80117-1-O |
DC3F/AD-II (cluster #1 Of 2), Other |
Other |
110 |
0.41 |
Functional ≤ 10μM
|
Z80125-8-O |
DU-145 (Prostate Carcinoma) (cluster #8 Of 9), Other |
Other |
170 |
0.39 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
99 |
0.41 |
Functional ≤ 10μM |
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
470 |
0.37 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
90 |
0.41 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
960 |
0.35 |
Functional ≤ 10μM
|
Z80244-3-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #3 Of 7), Other |
Other |
270 |
0.38 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
51 |
0.43 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
535 |
0.37 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
48 |
0.43 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
993 |
0.35 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.48 |
Functional ≤ 10μM
|
Z80647-1-O |
833K Cell Line (cluster #1 Of 1), Other |
Other |
328 |
0.38 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4500 |
0.31 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
400 |
0.37 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80776-1-O |
Clone 62 Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80888-1-O |
H2987 Cell Line (cluster #1 Of 1), Other |
Other |
1600 |
0.34 |
Functional ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 4), Other |
Other |
1700 |
0.34 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.47 |
Functional ≤ 10μM
|
Z81020-2-O |
HepG2 (Hepatoblastoma Cells) (cluster #2 Of 8), Other |
Other |
5400 |
0.31 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.36 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
810 |
0.36 |
Functional ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
800 |
0.36 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
70 |
0.42 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
4030 |
0.31 |
ADME/T ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
400 |
0.37 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.23 |
-4.19 |
-10.5 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
Mid
Mid (pH 6-8)
|
-1.23 |
-4.19 |
-11.87 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
|
|
Analogs
-
13361676
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.85 |
11.85 |
-12.99 |
1 |
6 |
0 |
66 |
401.466 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KD4DL-1-E |
Lysine-specific Demethylase 4D-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3550 |
0.42 |
Binding ≤ 10μM |
Z101879-1-O |
Leptomonas Seymouri (cluster #1 Of 1), Other |
Other |
400 |
0.50 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
6310 |
0.40 |
Functional ≤ 10μM
|
Z50466-5-O |
Trypanosoma Cruzi (cluster #5 Of 8), Other |
Other |
210 |
0.52 |
Functional ≤ 10μM
|
Z80002-2-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
800 |
0.47 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
7 |
0.63 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
1650 |
0.45 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9960 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1130 |
0.46 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4210 |
0.42 |
Functional ≤ 10μM
|
Z80980-1-O |
HOS (Osteosarcoma Cells) (cluster #1 Of 2), Other |
Other |
1400 |
0.46 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
1800 |
0.45 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
250 |
0.51 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
2100 |
0.44 |
ADME/T ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 4), Other |
Other |
270 |
0.51 |
ADME/T ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
700 |
0.48 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.95 |
8.03 |
-10.63 |
0 |
3 |
0 |
43 |
242.274 |
0 |
↓
|
|
|
Analogs
-
4963505
-
-
8627344
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 10 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.16 |
7.53 |
-47.41 |
0 |
3 |
-1 |
57 |
241.266 |
2 |
↓
|
Lo
Low (pH 4.5-6)
|
3.16 |
6.72 |
-6.51 |
1 |
3 |
0 |
54 |
242.274 |
2 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50607-3-O |
Human Immunodeficiency Virus 1 (cluster #3 Of 10), Other |
Other |
4100 |
0.19 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
9000 |
0.18 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.18 |
-4.15 |
-22.34 |
5 |
10 |
0 |
170 |
538.464 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
2100 |
0.47 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.01 |
6.83 |
-42.13 |
0 |
3 |
-1 |
57 |
227.239 |
1 |
↓
|
Ref
Reference (pH 7)
|
1.97 |
7.31 |
-8.1 |
0 |
3 |
0 |
51 |
228.247 |
1 |
↓
|
Mid
Mid (pH 6-8)
|
3.01 |
0.7 |
-23.7 |
1 |
3 |
0 |
54 |
228.247 |
1 |
↓
|
|
|
Analogs
-
1530861
-
-
5850156
-
-
5850183
-
-
6424763
-
-
19144226
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 66 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.41 |
Binding ≤ 10μM
|
KCNH2-5-E |
HERG (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
2512 |
0.36 |
Binding ≤ 10μM
|
NQO2-1-E |
Quinone Reductase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Binding ≤ 10μM
|
PRIO-1-E |
Prion Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.34 |
Binding ≤ 10μM
|
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.45 |
Functional ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
400 |
0.41 |
Binding ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
77 |
0.45 |
Functional ≤ 10μM
|
Z100498-2-O |
Hepatocytes (cluster #2 Of 2), Other |
Other |
1900 |
0.36 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
1700 |
0.37 |
Functional ≤ 10μM
|
Z102013-2-O |
Plasmodium Malariae (cluster #2 Of 2), Other |
Other |
14 |
0.50 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
90 |
0.45 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
167 |
0.43 |
Functional ≤ 10μM
|
Z50424-2-O |
Cryptosporidium Parvum (cluster #2 Of 2), Other |
Other |
27 |
0.48 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
100 |
0.45 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
900 |
0.38 |
Functional ≤ 10μM
|
Z50468-2-O |
Giardia Intestinalis (cluster #2 Of 4), Other |
Other |
401 |
0.41 |
Functional ≤ 10μM
|
Z50473-4-O |
Plasmodium Berghei (cluster #4 Of 5), Other |
Other |
72 |
0.45 |
Functional ≤ 10μM
|
Z50474-1-O |
Plasmodium Yoelii (cluster #1 Of 1), Other |
Other |
106 |
0.44 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
40 |
0.47 |
Functional ≤ 10μM
|
Z81138-1-O |
ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other |
Other |
4000 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
9670 |
0.32 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 2), Other |
Other |
5100 |
0.34 |
ADME/T ≤ 10μM
|
Z80186-3-O |
K562 (Erythroleukemia Cells) (cluster #3 Of 3), Other |
Other |
32 |
0.48 |
ADME/T ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
64 |
0.46 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
8300 |
0.32 |
ADME/T ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
600 |
0.40 |
ADME/T ≤ 10μM
|
Z81135-5-O |
L6 (Skeletal Muscle Myoblast Cells) (cluster #5 Of 6), Other |
Other |
7700 |
0.33 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.01 |
10.55 |
-81.59 |
3 |
3 |
2 |
31 |
321.896 |
8 |
↓
|
|
|
Analogs
-
5850156
-
-
5850183
-
-
6424763
-
-
19144226
-
-
19144231
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 64 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.41 |
Binding ≤ 10μM
|
KCNH2-5-E |
HERG (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
2512 |
0.36 |
Binding ≤ 10μM
|
NQO2-1-E |
Quinone Reductase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Binding ≤ 10μM
|
PRIO-1-E |
Prion Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.34 |
Binding ≤ 10μM
|
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.45 |
Functional ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
400 |
0.41 |
Binding ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
77 |
0.45 |
Functional ≤ 10μM
|
Z100498-2-O |
Hepatocytes (cluster #2 Of 2), Other |
Other |
1900 |
0.36 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
1700 |
0.37 |
Functional ≤ 10μM
|
Z102013-2-O |
Plasmodium Malariae (cluster #2 Of 2), Other |
Other |
14 |
0.50 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
90 |
0.45 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
167 |
0.43 |
Functional ≤ 10μM
|
Z50424-2-O |
Cryptosporidium Parvum (cluster #2 Of 2), Other |
Other |
27 |
0.48 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
100 |
0.45 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
900 |
0.38 |
Functional ≤ 10μM
|
Z50468-2-O |
Giardia Intestinalis (cluster #2 Of 4), Other |
Other |
401 |
0.41 |
Functional ≤ 10μM
|
Z50473-4-O |
Plasmodium Berghei (cluster #4 Of 5), Other |
Other |
72 |
0.45 |
Functional ≤ 10μM
|
Z50474-1-O |
Plasmodium Yoelii (cluster #1 Of 1), Other |
Other |
106 |
0.44 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
40 |
0.47 |
Functional ≤ 10μM
|
Z81138-1-O |
ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other |
Other |
4000 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
9670 |
0.32 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 2), Other |
Other |
5100 |
0.34 |
ADME/T ≤ 10μM
|
Z80186-3-O |
K562 (Erythroleukemia Cells) (cluster #3 Of 3), Other |
Other |
32 |
0.48 |
ADME/T ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
64 |
0.46 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
8300 |
0.32 |
ADME/T ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
600 |
0.40 |
ADME/T ≤ 10μM
|
Z81135-5-O |
L6 (Skeletal Muscle Myoblast Cells) (cluster #5 Of 6), Other |
Other |
7700 |
0.33 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.01 |
10.55 |
-81.48 |
3 |
3 |
2 |
31 |
321.896 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 21 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ACV1B-1-E |
Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3000 |
0.29 |
Binding ≤ 10μM
|
ADCK4-1-E |
Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.29 |
Binding ≤ 10μM
|
BRAF-1-E |
Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.32 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.33 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.31 |
Binding ≤ 10μM
|
DDR2-1-E |
Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
710 |
0.32 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7800 |
0.26 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.28 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
39 |
0.38 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
KC1AL-1-E |
Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.39 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
220 |
0.35 |
Binding ≤ 10μM
|
KS6A1-1-E |
Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
320 |
0.34 |
Binding ≤ 10μM
|
KS6A6-1-E |
Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
250 |
0.34 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7800 |
0.26 |
Binding ≤ 10μM
|
M4K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3700 |
0.28 |
Binding ≤ 10μM
|
MK08-1-E |
Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
95 |
0.36 |
Binding ≤ 10μM
|
MK10-2-E |
C-Jun N-terminal Kinase 3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
90 |
0.37 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
78 |
0.37 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.38 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.38 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
72 |
0.37 |
Binding ≤ 10μM
|
MLTK-1-E |
Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.28 |
Binding ≤ 10μM
|
MP2K2-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9600 |
0.26 |
Binding ≤ 10μM
|
MRCKA-1-E |
Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6200 |
0.27 |
Binding ≤ 10μM
|
MRCKB-1-E |
Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.29 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.33 |
Binding ≤ 10μM
|
NLK-1-E |
Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.39 |
Binding ≤ 10μM
|
PGH1-1-E |
Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
2000 |
0.30 |
Binding ≤ 10μM
|
PTK6-1-E |
Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9000 |
0.26 |
Binding ≤ 10μM
|
Q5SC61-1-E |
Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.36 |
Binding ≤ 10μM
|
RAF1-1-E |
Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.31 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
24 |
0.40 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4600 |
0.28 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5300 |
0.27 |
Binding ≤ 10μM
|
ST32B-1-E |
Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
STK36-1-E |
Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.31 |
Binding ≤ 10μM
|
TGFR1-1-E |
TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7100 |
0.27 |
Binding ≤ 10μM
|
TGFR2-1-E |
TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.30 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.28 |
Binding ≤ 10μM
|
TNIK-1-E |
TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
820 |
0.32 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.29 |
Binding ≤ 10μM
|
TXK-1-E |
Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.28 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
80 |
0.37 |
Functional ≤ 10μM |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
TNFA-1-E |
TNF-alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
70 |
0.37 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
80 |
0.37 |
Functional ≤ 10μM |
Z102116-1-O |
Toxoplasma Gondii RH (cluster #1 Of 2), Other |
Other |
8500 |
0.26 |
Functional ≤ 10μM
|
Z50472-1-O |
Toxoplasma Gondii (cluster #1 Of 4), Other |
Other |
2500 |
0.29 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
940 |
0.31 |
Functional ≤ 10μM
|
Z80523-1-O |
SW1353 (cluster #1 Of 2), Other |
Other |
50 |
0.38 |
Functional ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
72 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.10 |
8.8 |
-21.46 |
1 |
4 |
0 |
59 |
377.444 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
3.10 |
9.25 |
-46.75 |
2 |
4 |
1 |
60 |
378.452 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
3.10 |
9.24 |
-46.38 |
2 |
4 |
1 |
60 |
378.452 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 35 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ACV1B-1-E |
Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3000 |
0.29 |
Binding ≤ 10μM
|
ADCK4-1-E |
Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.29 |
Binding ≤ 10μM
|
BRAF-1-E |
Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.32 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.33 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.31 |
Binding ≤ 10μM
|
DDR2-1-E |
Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
710 |
0.32 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7800 |
0.26 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.28 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
39 |
0.38 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
KC1AL-1-E |
Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.39 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
220 |
0.35 |
Binding ≤ 10μM
|
KS6A1-1-E |
Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
320 |
0.34 |
Binding ≤ 10μM
|
KS6A6-1-E |
Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
250 |
0.34 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7800 |
0.26 |
Binding ≤ 10μM
|
M4K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3700 |
0.28 |
Binding ≤ 10μM
|
MK08-1-E |
Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
95 |
0.36 |
Binding ≤ 10μM
|
MK10-2-E |
C-Jun N-terminal Kinase 3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
90 |
0.37 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
78 |
0.37 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.38 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.38 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
72 |
0.37 |
Binding ≤ 10μM
|
MLTK-1-E |
Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.28 |
Binding ≤ 10μM
|
MP2K2-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9600 |
0.26 |
Binding ≤ 10μM
|
MRCKA-1-E |
Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6200 |
0.27 |
Binding ≤ 10μM
|
MRCKB-1-E |
Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.29 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.33 |
Binding ≤ 10μM
|
NLK-1-E |
Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.39 |
Binding ≤ 10μM
|
PGH1-1-E |
Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
2000 |
0.30 |
Binding ≤ 10μM
|
PTK6-1-E |
Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9000 |
0.26 |
Binding ≤ 10μM
|
Q5SC61-1-E |
Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.36 |
Binding ≤ 10μM
|
RAF1-1-E |
Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.31 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
24 |
0.40 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4600 |
0.28 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5300 |
0.27 |
Binding ≤ 10μM
|
ST32B-1-E |
Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
STK36-1-E |
Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.31 |
Binding ≤ 10μM
|
TGFR1-1-E |
TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7100 |
0.27 |
Binding ≤ 10μM
|
TGFR2-1-E |
TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.30 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.28 |
Binding ≤ 10μM
|
TNIK-1-E |
TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
820 |
0.32 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.29 |
Binding ≤ 10μM
|
TXK-1-E |
Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.28 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
80 |
0.37 |
Functional ≤ 10μM |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.31 |
Functional ≤ 10μM
|
TNFA-1-E |
TNF-alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
70 |
0.37 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
80 |
0.37 |
Functional ≤ 10μM |
Z102116-1-O |
Toxoplasma Gondii RH (cluster #1 Of 2), Other |
Other |
8500 |
0.26 |
Functional ≤ 10μM
|
Z50472-1-O |
Toxoplasma Gondii (cluster #1 Of 4), Other |
Other |
2500 |
0.29 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
940 |
0.31 |
Functional ≤ 10μM
|
Z80523-1-O |
SW1353 (cluster #1 Of 2), Other |
Other |
50 |
0.38 |
Functional ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
72 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.10 |
8.81 |
-16.64 |
1 |
4 |
0 |
59 |
377.444 |
4 |
↓
|
Ref
Reference (pH 7)
|
3.10 |
8.8 |
-16.98 |
1 |
4 |
0 |
59 |
377.444 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
3.10 |
9.25 |
-46.22 |
2 |
4 |
1 |
60 |
378.452 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6900 |
0.19 |
Binding ≤ 10μM
|
ANKK1-1-E |
Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
BLK-1-E |
Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.22 |
Binding ≤ 10μM
|
BRAF-1-E |
Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
83 |
0.25 |
Binding ≤ 10μM
|
CDK19-1-E |
Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.24 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
390 |
0.23 |
Binding ≤ 10μM
|
CDK8-1-E |
Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
220 |
0.24 |
Binding ≤ 10μM
|
CSF1R-1-E |
Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8100 |
0.18 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.20 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.31 |
Binding ≤ 10μM
|
DDR2-1-E |
Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.27 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9100 |
0.18 |
Binding ≤ 10μM
|
EPHA1-1-E |
Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9800 |
0.18 |
Binding ≤ 10μM
|
EPHA2-1-E |
Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6200 |
0.19 |
Binding ≤ 10μM
|
EPHA3-1-E |
Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
880 |
0.22 |
Binding ≤ 10μM
|
EPHA4-1-E |
Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3900 |
0.19 |
Binding ≤ 10μM
|
EPHA5-1-E |
Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.21 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
430 |
0.23 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.22 |
Binding ≤ 10μM
|
EPHA8-1-E |
Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.24 |
Binding ≤ 10μM
|
EPHB1-1-E |
Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4900 |
0.19 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.23 |
Binding ≤ 10μM
|
FAK1-1-E |
Focal Adhesion Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7100 |
0.18 |
Binding ≤ 10μM
|
FAK2-1-E |
Protein-tyrosine Kinase 2-beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.22 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4300 |
0.19 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.19 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
360 |
0.23 |
Binding ≤ 10μM
|
HSPB1-1-E |
Heat Shock Protein Beta-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
58 |
0.26 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
260 |
0.24 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1200 |
0.21 |
Binding ≤ 10μM
|
LTK-1-E |
Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.21 |
Binding ≤ 10μM
|
LYN-1-E |
Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.20 |
Binding ≤ 10μM
|
M4K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
90 |
0.25 |
Binding ≤ 10μM
|
MERTK-1-E |
Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3700 |
0.19 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
98 |
0.25 |
Binding ≤ 10μM
|
MK10-1-E |
C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
62 |
0.26 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
220 |
0.24 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
19 |
0.28 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
89 |
0.25 |
Binding ≤ 10μM
|
MK15-1-E |
Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3000 |
0.20 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1600 |
0.21 |
Binding ≤ 10μM
|
MLTK-1-E |
Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.22 |
Binding ≤ 10μM
|
MRCKA-1-E |
Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9400 |
0.18 |
Binding ≤ 10μM
|
MRCKB-1-E |
Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.22 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.21 |
Binding ≤ 10μM
|
MUSK-1-E |
Muscle, Skeletal Receptor Tyrosine Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1900 |
0.21 |
Binding ≤ 10μM
|
NLK-1-E |
Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
NTRK1-1-E |
Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
770 |
0.22 |
Binding ≤ 10μM
|
NTRK2-1-E |
Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
570 |
0.22 |
Binding ≤ 10μM
|
NTRK3-1-E |
NT-3 Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.24 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1200 |
0.21 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
RAF1-1-E |
Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.21 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.23 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
86 |
0.25 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.29 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.29 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.28 |
Binding ≤ 10μM
|
TNFA-1-E |
TNF-alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.22 |
Binding ≤ 10μM
|
TNIK-1-E |
TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10 |
0.29 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.20 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
410 |
0.23 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3900 |
0.19 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7100 |
0.18 |
Binding ≤ 10μM
|
YES-1-E |
Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4900 |
0.19 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
18 |
0.28 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
18 |
0.28 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
18 |
0.28 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
18 |
0.28 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z102213-1-O |
Blood (cluster #1 Of 2), Other |
Other |
780 |
0.22 |
Functional ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
18 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.43 |
12.45 |
-17.33 |
2 |
8 |
0 |
81 |
527.669 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
40 |
0.35 |
Binding ≤ 10μM |
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.38 |
Binding ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
3 |
0.40 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.73 |
10.55 |
-20.77 |
1 |
5 |
0 |
60 |
477.305 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
340 |
0.31 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
340 |
0.31 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
340 |
0.31 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
65 |
0.35 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.36 |
Functional ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.36 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.36 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.36 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
41 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.22 |
11.72 |
-7.18 |
2 |
4 |
0 |
54 |
404.514 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
5.22 |
12.1 |
-39.76 |
3 |
4 |
1 |
55 |
405.522 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
900 |
0.29 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
900 |
0.29 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
900 |
0.29 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
380 |
0.31 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
900 |
0.29 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
44 |
0.36 |
Functional ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
44 |
0.36 |
Functional ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
44 |
0.36 |
Functional ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
44 |
0.36 |
Functional ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
990 |
0.29 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
44 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.22 |
11.73 |
-7.19 |
2 |
4 |
0 |
54 |
404.514 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
5.22 |
12.41 |
-89.76 |
4 |
4 |
2 |
56 |
406.53 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
5.22 |
12.09 |
-38.63 |
3 |
4 |
1 |
55 |
405.522 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CP3A4-2-E |
Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
480 |
0.20 |
ADME/T ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
3000 |
0.17 |
Functional ≤ 10μM
|
Z101839-1-O |
HIV-1 M:B_Lai (cluster #1 Of 1), Other |
Other |
9 |
0.25 |
Functional ≤ 10μM
|
Z50038-1-O |
Plasmodium Yoelii Yoelii (cluster #1 Of 2), Other |
Other |
5000 |
0.16 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
9 |
0.25 |
Functional ≤ 10μM
|
Z50614-1-O |
Human T-lymphotropic Virus 1 (cluster #1 Of 1), Other |
Other |
22 |
0.24 |
Functional ≤ 10μM
|
Z50658-3-O |
Human Immunodeficiency Virus 2 (cluster #3 Of 4), Other |
Other |
825 |
0.19 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
50 |
0.23 |
Functional ≤ 10μM
|
Z80295-1-O |
MT4 (Lymphocytes) (cluster #1 Of 8), Other |
Other |
50 |
0.23 |
Functional ≤ 10μM
|
Q4U254-2-V |
Human Rhinovirus A Protease (cluster #2 Of 3), Viral |
Viruses |
3 |
0.27 |
Binding ≤ 10μM
|
Q72874-1-V |
Human Immunodeficiency Virus Type 1 Protease (cluster #1 Of 3), Viral |
Viruses |
0 |
0.00 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.51 |
6.19 |
-23.76 |
4 |
9 |
0 |
118 |
613.803 |
12 |
↓
|
Mid
Mid (pH 6-8)
|
2.51 |
8.52 |
-69.54 |
5 |
9 |
1 |
119 |
614.811 |
12 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.34 |
-1.68 |
-9.33 |
3 |
5 |
0 |
76 |
334.354 |
3 |
↓
|
Lo
Low (pH 4.5-6)
|
3.34 |
-1.42 |
-81.02 |
5 |
5 |
2 |
79 |
336.37 |
3 |
↓
|
Lo
Low (pH 4.5-6)
|
3.34 |
-1.57 |
-38.28 |
4 |
5 |
1 |
78 |
335.362 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
180 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.37 |
10.97 |
-14.35 |
1 |
7 |
0 |
75 |
471.435 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.30 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
530 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.08 |
1.15 |
-12.72 |
1 |
6 |
0 |
65 |
421.884 |
6 |
↓
|
|
|
Analogs
-
34858628
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.28 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2600 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.22 |
2.23 |
-13.05 |
1 |
6 |
0 |
65 |
415.493 |
6 |
↓
|
|
|
Analogs
-
3978074
-
-
4245659
-
-
4245660
-
-
4467870
-
-
11592709
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 37 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KITH-1-E |
Thymidine Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7000 |
0.38 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.60 |
Functional ≤ 10μM
|
Z80295-1-O |
MT4 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
4 |
0.62 |
Functional ≤ 10μM
|
Z102020-1-O |
Porcine Endogenous Retrovirus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50459-2-O |
Leishmania Donovani (cluster #2 Of 8), Other |
Other |
3400 |
0.40 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
7 |
0.60 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
46 |
0.54 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
9600 |
0.37 |
Functional ≤ 10μM
|
Z50609-1-O |
Simian Immunodeficiency Virus (cluster #1 Of 2), Other |
Other |
12 |
0.58 |
Functional ≤ 10μM
|
Z50658-1-O |
Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50664-1-O |
Rauscher Murine Leukemia Virus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50737-1-O |
Human Immunodeficiency Virus 3 (cluster #1 Of 1), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80071-1-O |
CEM-0 (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80073-1-O |
CEM-c113 (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
95 |
0.52 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
6180 |
0.38 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80294-1-O |
MT2 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z80384-1-O |
PBL (Peripheral Blood Lymphocytes) (cluster #1 Of 1), Other |
Other |
29 |
0.56 |
Functional ≤ 10μM
|
Z80516-1-O |
SUP-T1 (cluster #1 Of 1), Other |
Other |
50 |
0.54 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80683-1-O |
ATH8 Cell Line (cluster #1 Of 1), Other |
Other |
400 |
0.47 |
Functional ≤ 10μM
|
Z80688-1-O |
B(EBV+) Cell Line (cluster #1 Of 1), Other |
Other |
1 |
0.66 |
Functional ≤ 10μM
|
Z80721-1-O |
BxT Cell Line (cluster #1 Of 1), Other |
Other |
55 |
0.53 |
Functional ≤ 10μM
|
Z80737-1-O |
C3H/3T3 (Embryonic Fibroblast Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Functional ≤ 10μM
|
Z80760-1-O |
CFU-GM Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.43 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM |
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z81223-1-O |
M Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.58 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 4), Other |
Other |
700 |
0.45 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
45 |
0.54 |
ADME/T ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72874-1-V |
Human Immunodeficiency Virus Type 1 Protease (cluster #1 Of 3), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 1), Viral |
Viruses |
8 |
0.60 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.10 |
-3.76 |
-14.65 |
2 |
9 |
0 |
134 |
267.245 |
3 |
↓
|
|
|
Analogs
-
3881944
-
-
3881945
-
-
3881946
-
-
5275964
-
-
5276791
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ANDR-2-E |
Androgen Receptor (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
2762 |
0.30 |
Binding ≤ 10μM
|
FABPL-1-E |
Fatty Acid-binding Protein, Liver (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2660 |
0.30 |
Binding ≤ 10μM
|
GCR-2-E |
Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.44 |
Binding ≤ 10μM
|
GLNA-1-E |
Glutamine Synthetase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.40 |
Binding ≤ 10μM
|
MCR-1-E |
Mineralocorticoid Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
37 |
0.40 |
Binding ≤ 10μM
|
GCR-2-E |
Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.41 |
Functional ≤ 10μM
|
MCR-2-E |
Mineralocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
25 |
0.41 |
Functional ≤ 10μM
|
Z50594-7-O |
Mus Musculus (cluster #7 Of 9), Other |
Other |
6 |
0.44 |
Functional ≤ 10μM
|
Z80110-2-O |
CV-1 (Kidney Cells) (cluster #2 Of 2), Other |
Other |
8 |
0.44 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
760 |
0.33 |
Functional ≤ 10μM
|
Z80682-3-O |
A549 (Lung Carcinoma Cells) (cluster #3 Of 11), Other |
Other |
5 |
0.45 |
Functional ≤ 10μM
|
Z80954-3-O |
HFF (Foreskin Fibroblasts) (cluster #3 Of 4), Other |
Other |
7 |
0.44 |
Functional ≤ 10μM
|
Z81011-3-O |
Human Cell Lines (cluster #3 Of 3), Other |
Other |
48 |
0.39 |
Functional ≤ 10μM
|
Z81247-4-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #4 Of 9), Other |
Other |
16 |
0.42 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.60 |
3.09 |
-16.14 |
3 |
5 |
0 |
95 |
360.45 |
2 |
↓
|
|
|
|
|
Analogs
-
3830334
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 18 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GCR-2-E |
Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.38 |
Binding ≤ 10μM
|
GCR-2-E |
Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
12 |
0.36 |
Functional ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
1 |
0.41 |
Functional ≤ 10μM |
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
3162 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.19 |
6.66 |
-12.84 |
2 |
6 |
0 |
93 |
430.541 |
4 |
↓
|
|
|
Analogs
-
16952920
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 56 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
27 |
0.71 |
Functional ≤ 10μM
|
Z101829-1-O |
HBV Genotype D (cluster #1 Of 1), Other |
Other |
460 |
0.59 |
Functional ≤ 10μM
|
Z50518-3-O |
Human Herpesvirus 4 (cluster #3 Of 5), Other |
Other |
400 |
0.60 |
Functional ≤ 10μM
|
Z50602-2-O |
Human Herpesvirus 1 (cluster #2 Of 5), Other |
Other |
2200 |
0.53 |
Functional ≤ 10μM
|
Z50606-1-O |
Hepatitis B Virus (cluster #1 Of 3), Other |
Other |
81 |
0.66 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
969 |
0.56 |
Functional ≤ 10μM
|
Z50658-1-O |
Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other |
Other |
2000 |
0.53 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
60 |
0.67 |
Functional ≤ 10μM
|
Z50681-1-O |
Duck Hepatitis B Virus (cluster #1 Of 2), Other |
Other |
44 |
0.69 |
Functional ≤ 10μM
|
Z50755-1-O |
Anas Sp. (cluster #1 Of 1), Other |
Other |
100 |
0.65 |
Functional ≤ 10μM |
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
7000 |
0.48 |
Functional ≤ 10μM |
Z80947-1-O |
Hepatoblastoma Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.67 |
Functional ≤ 10μM
|
Z80949-1-O |
Hepatoma Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.75 |
Functional ≤ 10μM |
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other |
Other |
8 |
0.76 |
Functional ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
42 |
0.69 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.09 |
-2.17 |
-16.53 |
3 |
6 |
0 |
90 |
229.261 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 68 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-3-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #3 Of 4), Other |
Other |
150 |
0.96 |
Functional ≤ 10μM
|
Z50425-15-O |
Plasmodium Falciparum (cluster #15 Of 22), Other |
Other |
2000 |
0.80 |
Functional ≤ 10μM
|
Z80064-3-O |
CCRF-CEM (T-cell Leukemia) (cluster #3 Of 9), Other |
Other |
1000 |
0.84 |
Functional ≤ 10μM
|
Z80068-2-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #2 Of 5), Other |
Other |
1000 |
0.84 |
Functional ≤ 10μM
|
Z80125-5-O |
DU-145 (Prostate Carcinoma) (cluster #5 Of 9), Other |
Other |
2000 |
0.80 |
Functional ≤ 10μM
|
Z80193-6-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #6 Of 12), Other |
Other |
24 |
1.07 |
Functional ≤ 10μM
|
Z80224-4-O |
MCF7 (Breast Carcinoma Cells) (cluster #4 Of 14), Other |
Other |
5800 |
0.73 |
Functional ≤ 10μM
|
Z80295-4-O |
MT4 (Lymphocytes) (cluster #4 Of 8), Other |
Other |
100 |
0.98 |
Functional ≤ 10μM
|
Z80936-3-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #3 Of 4), Other |
Other |
7 |
1.14 |
Functional ≤ 10μM
|
Z81020-5-O |
HepG2 (Hepatoblastoma Cells) (cluster #5 Of 8), Other |
Other |
8000 |
0.71 |
Functional ≤ 10μM
|
Z81247-5-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #5 Of 9), Other |
Other |
4100 |
0.75 |
Functional ≤ 10μM
|
Z80178-1-O |
J774.A1 (Macrophage Cells) (cluster #1 Of 2), Other |
Other |
3 |
1.19 |
ADME/T ≤ 10μM
|
Z80936-3-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #3 Of 4), Other |
Other |
7 |
1.14 |
ADME/T ≤ 10μM
|
Z81244-2-O |
J774 (Macrophage Cells) (cluster #2 Of 3), Other |
Other |
3 |
1.19 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.39 |
4.06 |
-18.68 |
2 |
4 |
0 |
57 |
152.182 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
0.34 |
3.67 |
-44.86 |
1 |
4 |
-1 |
54 |
151.174 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
0.34 |
3.66 |
-43.68 |
1 |
4 |
-1 |
54 |
151.174 |
0 |
↓
|
|
|
Analogs
-
16025885
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 47 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.95 |
1.07 |
-21.3 |
2 |
7 |
0 |
93 |
236.231 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
-0.49 |
-0.99 |
-55.12 |
1 |
7 |
-1 |
96 |
235.223 |
2 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 28 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-3-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #3 Of 4), Other |
Other |
230 |
0.49 |
Functional ≤ 10μM
|
Z50425-15-O |
Plasmodium Falciparum (cluster #15 Of 22), Other |
Other |
10000 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.50 |
7.86 |
-28.67 |
1 |
9 |
0 |
118 |
277.269 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
0.50 |
7.39 |
-51.02 |
0 |
9 |
-1 |
116 |
276.261 |
3 |
↓
|
|
|
Analogs
-
4095791
-
-
12501465
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AAK1-1-E |
Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
AAPK1-1-E |
AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
AAPK2-1-E |
AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
12 |
0.32 |
Binding ≤ 10μM
|
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
91 |
0.28 |
Binding ≤ 10μM
|
ABL2-1-E |
Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.27 |
Binding ≤ 10μM
|
ACK1-1-E |
Tyrosine Kinase Non-receptor Protein 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
ACV1B-1-E |
Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.25 |
Binding ≤ 10μM
|
ACVR1-1-E |
Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.25 |
Binding ≤ 10μM
|
AKT1-2-E |
RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
AKT2-2-E |
Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
AKT3-2-E |
Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
ALK-1-E |
ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
ANKK1-1-E |
Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
22 |
0.31 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
AVR2B-1-E |
Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4600 |
0.21 |
Binding ≤ 10μM
|
BLK-1-E |
Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
15 |
0.31 |
Binding ≤ 10μM
|
BMP2K-1-E |
BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
BMR1A-1-E |
Bone Morphogenetic Protein Receptor Type-1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3700 |
0.22 |
Binding ≤ 10μM
|
BMX-1-E |
Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
410 |
0.26 |
Binding ≤ 10μM
|
BRSK1-1-E |
BR Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
BRSK2-1-E |
BR Serine/threonine-protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
BTK-1-E |
Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.25 |
Binding ≤ 10μM
|
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNE1-1-E |
G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
CCNE2-1-E |
G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CDK14-1-E |
Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.27 |
Binding ≤ 10μM
|
CDK16-1-E |
Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.30 |
Binding ≤ 10μM
|
CDK17-1-E |
Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
96 |
0.28 |
Binding ≤ 10μM
|
CDK18-1-E |
Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
CDK19-1-E |
Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CDK3-1-E |
Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CDK4-2-E |
Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
18 |
0.31 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
89 |
0.28 |
Binding ≤ 10μM
|
CDK6-1-E |
Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
116 |
0.28 |
Binding ≤ 10μM
|
CDK7-1-E |
Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.29 |
Binding ≤ 10μM
|
CDK8-1-E |
Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
510 |
0.25 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
CHK1-1-E |
Serine/threonine-protein Kinase Chk1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
CHK2-1-E |
Serine/threonine-protein Kinase Chk2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CLK1-2-E |
Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
CLK2-1-E |
Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.24 |
Binding ≤ 10μM
|
CLK4-1-E |
Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
CSF1R-1-E |
Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
12 |
0.32 |
Binding ≤ 10μM
|
CSK-1-E |
Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.25 |
Binding ≤ 10μM
|
CSK21-1-E |
Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7620 |
0.20 |
Binding ≤ 10μM
|
CSK22-1-E |
Casein Kinase II Alpha (prime) (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CSK2B-1-E |
Casein Kinase II Beta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7000 |
0.21 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
340 |
0.26 |
Binding ≤ 10μM
|
DAPK1-1-E |
Death-associated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
DAPK2-1-E |
Death-associated Protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1500 |
0.23 |
Binding ≤ 10μM
|
DCLK1-1-E |
Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.28 |
Binding ≤ 10μM
|
DCLK2-1-E |
Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
73 |
0.29 |
Binding ≤ 10μM
|
DCLK3-1-E |
Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
DDR2-1-E |
Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
DMPK-1-E |
Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
DYR1B-1-E |
Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.28 |
Binding ≤ 10μM |
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
360 |
0.26 |
Binding ≤ 10μM
|
E2AK4-1-E |
Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
96 |
0.28 |
Binding ≤ 10μM
|
EPHA1-1-E |
Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
EPHA2-1-E |
Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
870 |
0.24 |
Binding ≤ 10μM
|
EPHA3-1-E |
Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
55 |
0.29 |
Binding ≤ 10μM
|
EPHA4-1-E |
Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.25 |
Binding ≤ 10μM
|
EPHA5-1-E |
Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
95 |
0.28 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
290 |
0.26 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.25 |
Binding ≤ 10μM
|
EPHA8-1-E |
Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
EPHB1-1-E |
Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
590 |
0.25 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.23 |
Binding ≤ 10μM
|
EPHB4-1-E |
Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
233 |
0.27 |
Binding ≤ 10μM
|
ERBB4-1-E |
Receptor Protein-tyrosine Kinase ErbB-4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
282 |
0.26 |
Binding ≤ 10μM
|
FAK1-1-E |
Focal Adhesion Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
68 |
0.29 |
Binding ≤ 10μM
|
FAK2-1-E |
Protein-tyrosine Kinase 2-beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
FER-1-E |
Tyrosine-protein Kinase FER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
FES-1-E |
Tyrosine-protein Kinase FES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
90 |
0.28 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
FGFR3-1-E |
Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
88 |
0.28 |
Binding ≤ 10μM
|
FGFR4-1-E |
Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
FGR-1-E |
Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.29 |
Binding ≤ 10μM
|
FYN-1-E |
Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
83 |
0.28 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
68 |
0.29 |
Binding ≤ 10μM
|
GSK3A-1-E |
Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
140 |
0.27 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
89 |
0.28 |
Binding ≤ 10μM
|
HCK-1-E |
Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
HIPK1-1-E |
Homeodomain-interacting Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2639 |
0.22 |
Binding ≤ 10μM
|
IGF1R-1-E |
Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
IKKA-2-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
39 |
0.30 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
771 |
0.24 |
Binding ≤ 10μM
|
IKKE-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
INSR-1-E |
Insulin Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.27 |
Binding ≤ 10μM
|
INSRR-1-E |
Insulin Receptor-related Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
81 |
0.28 |
Binding ≤ 10μM
|
IRAK3-1-E |
Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.32 |
Binding ≤ 10μM
|
IRAK4-1-E |
Interleukin-1 Receptor-associated Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
34 |
0.30 |
Binding ≤ 10μM
|
ITK-1-E |
Tyrosine-protein Kinase ITK/TSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
JAK3-1-E |
Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KAP2-1-E |
CAMP-dependent Protein Kinase Type II-alpha Regulatory Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.28 |
Binding ≤ 10μM
|
KAPCA-1-E |
CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
27 |
0.30 |
Binding ≤ 10μM
|
KAPCB-1-E |
CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
KAPCG-1-E |
CAMP-dependent Protein Kinase, Gamma Catalytic Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
80 |
0.28 |
Binding ≤ 10μM
|
KC1A-1-E |
Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1AL-1-E |
Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
250 |
0.26 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1G1-1-E |
Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1G2-1-E |
Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.24 |
Binding ≤ 10μM
|
KCC1A-1-E |
CaM Kinase I Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
KCC1D-1-E |
CaM Kinase I Delta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
KCC1G-1-E |
CaM Kinase I Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
53 |
0.29 |
Binding ≤ 10μM
|
KCC2A-1-E |
CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2B-1-E |
CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2D-1-E |
CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2G-1-E |
CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC4-1-E |
CaM Kinase IV (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.30 |
Binding ≤ 10μM
|
KGP1-1-E |
CGMP-dependent Protein Kinase 1 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
KGP2-1-E |
CGMP-dependent Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
KKCC1-1-E |
CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
KKCC2-1-E |
CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
KPB1-1-E |
Phosphorylase Kinase Alpha M Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPB2-1-E |
Phosphorylase Kinase Alpha L Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPBB-1-E |
Phosphorylase Kinase Beta Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPCA-1-E |
Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCD-1-E |
Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCD1-1-E |
Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCD2-1-E |
Serine/threonine-protein Kinase D2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
72 |
0.29 |
Binding ≤ 10μM
|
KPCD3-1-E |
Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCE-1-E |
Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCG-1-E |
Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCI-1-E |
Protein Kinase C Iota (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCL-2-E |
Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCZ-1-E |
Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KS6A1-1-E |
Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6A2-1-E |
Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
KS6A3-1-E |
Ribosomal Protein S6 Kinase Alpha 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
69 |
0.29 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6A5-1-E |
Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
890 |
0.24 |
Binding ≤ 10μM
|
KS6A6-1-E |
Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6B1-1-E |
Ribosomal Protein S6 Kinase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6B2-1-E |
Ribosomal Protein S6 Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KSYK-1-E |
Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
LATS1-1-E |
Serine/threonine-protein Kinase LATS1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
LATS2-1-E |
Serine/threonine-protein Kinase LATS2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
LIMK1-1-E |
LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.25 |
Binding ≤ 10μM
|
LIMK2-1-E |
LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9200 |
0.20 |
Binding ≤ 10μM
|
LTK-1-E |
Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
LYN-1-E |
Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
M3K10-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
M3K11-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
M3K14-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 14 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.23 |
Binding ≤ 10μM
|
M3K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2200 |
0.23 |
Binding ≤ 10μM
|
M3K5-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
M3K7-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
M3K9-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
M4K1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
M4K3-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
M4K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
24 |
0.30 |
Binding ≤ 10μM
|
M4K5-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
MAPK2-1-E |
MAP Kinase-activated Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
880 |
0.24 |
Binding ≤ 10μM
|
MARK1-1-E |
Serine/threonine-protein Kinase MARK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
MARK2-1-E |
MAP/microtubule Affinity-regulating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
MARK3-1-E |
Serine/threonine-protein Kinase C-TAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
MARK4-1-E |
MAP/microtubule Affinity-regulating Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
MELK-1-E |
Maternal Embryonic Leucine Zipper Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.30 |
Binding ≤ 10μM
|
MERTK-1-E |
Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
MINK1-1-E |
Misshapen-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MK01-1-E |
Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7300 |
0.21 |
Binding ≤ 10μM
|
MK03-1-E |
MAP Kinase ERK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8400 |
0.20 |
Binding ≤ 10μM
|
MK07-1-E |
Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.23 |
Binding ≤ 10μM
|
MK08-1-E |
Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
520 |
0.25 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.24 |
Binding ≤ 10μM
|
MK10-1-E |
C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
340 |
0.26 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
92 |
0.28 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK15-1-E |
Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
170 |
0.27 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
22 |
0.31 |
Binding ≤ 10μM
|
MP2K1-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
670 |
0.25 |
Binding ≤ 10μM
|
MP2K2-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
MP2K3-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
MP2K4-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.29 |
Binding ≤ 10μM
|
MP2K6-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
MRCKA-1-E |
Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
57 |
0.29 |
Binding ≤ 10μM
|
MRCKB-1-E |
Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
MST4-1-E |
Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
140 |
0.27 |
Binding ≤ 10μM
|
MUSK-1-E |
Muscle, Skeletal Receptor Tyrosine Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
86 |
0.28 |
Binding ≤ 10μM
|
MYLK-1-E |
Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
MYLK2-1-E |
Myosin Light Chain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
MYLK4-1-E |
Myosin Light Chain Kinase Family Member 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.25 |
Binding ≤ 10μM
|
MYO3A-1-E |
Myosin IIIA (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.25 |
Binding ≤ 10μM
|
MYO3B-1-E |
Myosin-IIIB (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
NEK1-1-E |
Serine/threonine-protein Kinase Nek1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.24 |
Binding ≤ 10μM
|
NEK2-1-E |
Serine/threonine-protein Kinase NEK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
750 |
0.24 |
Binding ≤ 10μM
|
NEK5-1-E |
Serine/threonine-protein Kinase Nek5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
810 |
0.24 |
Binding ≤ 10μM
|
NEK7-1-E |
Serine/threonine-protein Kinase NEK7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.21 |
Binding ≤ 10μM
|
NEK9-1-E |
Serine/threonine-protein Kinase NEK9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6700 |
0.21 |
Binding ≤ 10μM
|
NLK-1-E |
Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
220 |
0.27 |
Binding ≤ 10μM
|
NTRK1-1-E |
Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NTRK2-1-E |
Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NTRK3-1-E |
NT-3 Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
NUAK1-1-E |
NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NUAK2-1-E |
NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
P90584-2-E |
Protein Kinase Pfmrk (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
4000 |
0.22 |
Binding ≤ 10μM
|
PAK1-1-E |
Serine/threonine-protein Kinase PAK 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PAK2-1-E |
Serine/threonine-protein Kinase PAK 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PAK3-1-E |
Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
PAK4-1-E |
Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
PAK6-1-E |
Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PAK7-1-E |
Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PDPK1-1-E |
3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PHKG1-1-E |
Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM |
PHKG2-1-E |
Phosphorylase Kinase Gamma Subunit 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM |
PI42B-1-E |
Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Binding ≤ 10μM
|
PI51A-1-E |
Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
PIM2-1-E |
Serine/threonine-protein Kinase PIM2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
PIM3-1-E |
Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PKN1-1-E |
Protein Kinase N1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PKN2-1-E |
Protein Kinase N2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
PLK2-1-E |
Serine/threonine-protein Kinase PLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
197 |
0.27 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.24 |
Binding ≤ 10μM
|
PLK4-1-E |
Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PRKX-1-E |
Serine/threonine-protein Kinase PRKX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.32 |
Binding ≤ 10μM
|
PTK6-1-E |
Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.23 |
Binding ≤ 10μM
|
Q95J97-1-E |
CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
80 |
0.28 |
Binding ≤ 10μM
|
RAF1-1-E |
Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
RIOK1-1-E |
Serine/threonine-protein Kinase RIO1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
130 |
0.28 |
Binding ≤ 10μM
|
RIOK3-1-E |
Serine/threonine-protein Kinase RIO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
76 |
0.28 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5200 |
0.21 |
Binding ≤ 10μM
|
ROCK1-1-E |
Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
ROS1-1-E |
Proto-oncogene Tyrosine-protein Kinase ROS (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
SIK1-1-E |
Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
SIK2-1-E |
Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
86 |
0.28 |
Binding ≤ 10μM
|
SRMS-1-E |
Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.25 |
Binding ≤ 10μM
|
SRPK1-1-E |
Serine/threonine-protein Kinase SRPK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
SRPK2-1-E |
Serine/threonine-protein Kinase SRPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
67 |
0.29 |
Binding ≤ 10μM
|
ST17A-1-E |
Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
ST17B-1-E |
Serine/threonine-protein Kinase 17B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
ST32B-1-E |
Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
98 |
0.28 |
Binding ≤ 10μM
|
ST32C-1-E |
Serine/threonine-protein Kinase 32C (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
310 |
0.26 |
Binding ≤ 10μM
|
ST38L-1-E |
Serine/threonine-protein Kinase 38-like (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
STK11-1-E |
Serine/threonine-protein Kinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
STK16-1-E |
Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
STK24-1-E |
Serine/threonine-protein Kinase 24 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.28 |
Binding ≤ 10μM
|
STK25-1-E |
Serine/threonine-protein Kinase 25 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.28 |
Binding ≤ 10μM
|
STK3-1-E |
Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
STK33-1-E |
Serine/threonine-protein Kinase 33 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
STK36-1-E |
Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6700 |
0.21 |
Binding ≤ 10μM
|
STK4-1-E |
Serine/threonine-protein Kinase MST1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
SYK-1-E |
Lysyl-tRNA Synthetase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
TAB1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
770 |
0.24 |
Binding ≤ 10μM
|
TEC-1-E |
Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.24 |
Binding ≤ 10μM
|
TESK1-1-E |
Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
320 |
0.26 |
Binding ≤ 10μM
|
TGFR1-1-E |
TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
65 |
0.29 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
TLK1-1-E |
Serine/threonine-protein Kinase Tousled-like 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
27 |
0.30 |
Binding ≤ 10μM
|
TLK2-1-E |
Serine/threonine-protein Kinase Tousled-like 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
TNIK-1-E |
TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
TNK1-1-E |
Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
TSSK1-1-E |
Testis-specific Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
24 |
0.30 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
TXK-1-E |
Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
230 |
0.27 |
Binding ≤ 10μM
|
TYK2-1-E |
Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.29 |
Binding ≤ 10μM
|
TYRO3-1-E |
Tyrosine-protein Kinase Receptor TYRO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
49 |
0.29 |
Binding ≤ 10μM
|
UFO-1-E |
Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
ULK3-1-E |
Serine/threonine-protein Kinase ULK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
14 |
0.31 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
88 |
0.28 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
14 |
0.31 |
Binding ≤ 10μM
|
WEE1-1-E |
Serine/threonine-protein Kinase WEE1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.23 |
Binding ≤ 10μM
|
YES-1-E |
Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
ZAP70-1-E |
Tyrosine-protein Kinase ZAP-70 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
53 |
0.29 |
Binding ≤ 10μM
|
AKT1-1-E |
Serine/threonine-protein Kinase AKT (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
460 |
0.25 |
Functional ≤ 10μM
|
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Functional ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
10 |
0.32 |
Binding ≤ 10μM
|
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
59 |
0.29 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
16 |
0.31 |
Functional ≤ 10μM
|
Z100201-1-O |
Splenocytes (Spleen Cells) (cluster #1 Of 1), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
190 |
0.27 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
7500 |
0.20 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9 |
0.32 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3 |
0.34 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
1 |
0.36 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
50 |
0.29 |
Functional ≤ 10μM
|
Z80800-1-O |
MIA PaCa-2 (Pancreatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
370 |
0.26 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6 |
0.33 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
77 |
0.28 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
4 |
0.34 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
71 |
0.29 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.89 |
8.49 |
-39.52 |
3 |
7 |
1 |
74 |
467.549 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.89 |
8.85 |
-16.32 |
2 |
7 |
0 |
69 |
466.541 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GCR-2-E |
Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Functional ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.89 |
4.25 |
-22.44 |
1 |
6 |
0 |
93 |
538.584 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 13 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
8000 |
0.26 |
Binding ≤ 10μM |
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
50 |
0.38 |
Functional ≤ 10μM |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
50 |
0.38 |
Functional ≤ 10μM |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
3162 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.22 |
10.93 |
-10.99 |
1 |
6 |
0 |
87 |
360.348 |
4 |
↓
|
Ref
Reference (pH 7)
|
4.22 |
10.58 |
-13.35 |
1 |
6 |
0 |
87 |
360.348 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GLR-2-E |
Glucagon Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
490 |
0.34 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
2700 |
0.30 |
Binding ≤ 10μM |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.37 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
120 |
0.37 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.37 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
120 |
0.37 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
580 |
0.34 |
Functional ≤ 10μM |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
580 |
0.34 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.70 |
11.23 |
-8.24 |
1 |
3 |
0 |
42 |
361.445 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
4.70 |
11.67 |
-35.88 |
2 |
3 |
1 |
43 |
362.453 |
4 |
↓
|
Lo
Low (pH 4.5-6)
|
4.70 |
11.66 |
-35.83 |
2 |
3 |
1 |
43 |
362.453 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GLR-2-E |
Glucagon Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.32 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.40 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
70 |
0.40 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.40 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
70 |
0.40 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
50 |
0.41 |
Functional ≤ 10μM |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
50 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.34 |
8.53 |
-32.51 |
4 |
4 |
1 |
69 |
331.374 |
3 |
↓
|
Ref
Reference (pH 7)
|
3.34 |
8.52 |
-32.39 |
4 |
4 |
1 |
69 |
331.374 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
3.34 |
8.09 |
-8.76 |
3 |
4 |
0 |
68 |
330.366 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
34 |
0.35 |
Binding ≤ 10μM |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
156 |
0.32 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.52 |
10.57 |
-17.99 |
1 |
5 |
0 |
60 |
477.305 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 27 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.04 |
2.29 |
-156.31 |
9 |
8 |
3 |
89 |
505.82 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
2.94 |
7.04 |
-11.84 |
1 |
10 |
0 |
126 |
459.499 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
8 |
0.57 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.28 |
7.16 |
-9.1 |
2 |
3 |
0 |
49 |
260.296 |
1 |
↓
|
|
|
Analogs
-
560899
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
-0.05 |
-10.56 |
1 |
4 |
0 |
51 |
281.311 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 18 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
3 |
0.46 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.26 |
8.04 |
-10.47 |
1 |
5 |
0 |
60 |
403.212 |
7 |
↓
|
|
|
Analogs
-
38214908
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
8700 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.56 |
1.57 |
-11.83 |
3 |
9 |
0 |
128 |
377.408 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
IKKA-2-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
70 |
0.29 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.29 |
Binding ≤ 10μM
|
NEMO-1-E |
NF-kappa-B Essential Modulator (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.29 |
Binding ≤ 10μM
|
IKKA-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.25 |
Functional ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.25 |
Functional ≤ 10μM
|
JAK1-1-E |
Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Functional ≤ 10μM
|
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Functional ≤ 10μM
|
NEMO-1-E |
NF-kappa-B Essential Modulator (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.25 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
300 |
0.26 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.88 |
16.15 |
-47.35 |
2 |
6 |
1 |
63 |
484.649 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.27 |
0.05 |
-47.77 |
2 |
8 |
-1 |
111 |
314.325 |
6 |
↓
|
Mid
Mid (pH 6-8)
|
1.81 |
1.92 |
-11.81 |
3 |
8 |
0 |
108 |
315.333 |
6 |
↓
|
Lo
Low (pH 4.5-6)
|
2.27 |
-8.3 |
-36.44 |
4 |
8 |
1 |
109 |
316.341 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.97 |
11.58 |
-55.4 |
0 |
8 |
-1 |
108 |
554.435 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
IKKA-2-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.40 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.48 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.40 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
800 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.33 |
4.58 |
-50.15 |
4 |
5 |
1 |
70 |
256.333 |
3 |
↓
|
Lo
Low (pH 4.5-6)
|
1.33 |
5.07 |
-92.92 |
5 |
5 |
2 |
71 |
257.341 |
3 |
↓
|
|
|
Analogs
-
34394107
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
15 |
0.39 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.43 |
Binding ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
61 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.11 |
0.43 |
-21.76 |
3 |
9 |
0 |
109 |
382.424 |
6 |
↓
|
|